JP4070138B2 - 加工ニンニク、およびその処理方法 - Google Patents
加工ニンニク、およびその処理方法 Download PDFInfo
- Publication number
- JP4070138B2 JP4070138B2 JP2004381423A JP2004381423A JP4070138B2 JP 4070138 B2 JP4070138 B2 JP 4070138B2 JP 2004381423 A JP2004381423 A JP 2004381423A JP 2004381423 A JP2004381423 A JP 2004381423A JP 4070138 B2 JP4070138 B2 JP 4070138B2
- Authority
- JP
- Japan
- Prior art keywords
- garlic
- treatment
- temperature
- component
- propenylcysteine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000004611 garlic Nutrition 0.000 title claims description 152
- 238000003672 processing method Methods 0.000 title claims description 12
- 244000245420 ail Species 0.000 title 1
- 240000002234 Allium sativum Species 0.000 claims description 152
- ZFAHNWWNDFHPOH-YFKPBYRVSA-N S-allylcysteine Chemical compound OC(=O)[C@@H](N)CSCC=C ZFAHNWWNDFHPOH-YFKPBYRVSA-N 0.000 claims description 113
- 238000011282 treatment Methods 0.000 claims description 109
- ZFAHNWWNDFHPOH-UHFFFAOYSA-N S-Allyl-L-cystein Natural products OC(=O)C(N)CSCC=C ZFAHNWWNDFHPOH-UHFFFAOYSA-N 0.000 claims description 50
- 238000003860 storage Methods 0.000 claims description 37
- 230000005059 dormancy Effects 0.000 claims description 31
- 238000003306 harvesting Methods 0.000 claims description 19
- 238000010792 warming Methods 0.000 claims description 17
- 230000001766 physiological effect Effects 0.000 claims description 15
- 238000009825 accumulation Methods 0.000 claims description 12
- FUTHBNRZCFKVQZ-UHFFFAOYSA-N gamma-L-Glutamyl-S-allyl-L-cysteine Natural products OC(=O)C(N)CCC(=O)NC(C(O)=O)CSCC=C FUTHBNRZCFKVQZ-UHFFFAOYSA-N 0.000 claims description 10
- FUTHBNRZCFKVQZ-YUMQZZPRSA-N (2s)-2-amino-5-[[(1r)-1-carboxy-2-prop-2-enylsulfanylethyl]amino]-5-oxopentanoic acid Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(O)=O)CSCC=C FUTHBNRZCFKVQZ-YUMQZZPRSA-N 0.000 claims description 9
- 108010039146 gamma-glutamyl-S-allylcysteine Proteins 0.000 claims description 9
- 230000007246 mechanism Effects 0.000 claims description 9
- 206010067125 Liver injury Diseases 0.000 claims description 5
- 231100000234 hepatic damage Toxicity 0.000 claims description 5
- 230000008818 liver damage Effects 0.000 claims description 5
- 230000003405 preventing effect Effects 0.000 claims description 5
- 230000001256 tonic effect Effects 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000004936 stimulating effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- 238000012545 processing Methods 0.000 description 26
- 238000000034 method Methods 0.000 description 24
- 239000004480 active ingredient Substances 0.000 description 20
- 239000007864 aqueous solution Substances 0.000 description 20
- 238000007654 immersion Methods 0.000 description 19
- 239000000126 substance Substances 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 12
- 230000008859 change Effects 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 239000000523 sample Substances 0.000 description 8
- 230000007423 decrease Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000007958 sleep Effects 0.000 description 6
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 5
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 5
- 235000010081 allicin Nutrition 0.000 description 5
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 5
- 235000018417 cysteine Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 238000005057 refrigeration Methods 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 241000234282 Allium Species 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000007598 dipping method Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 3
- 230000005058 diapause Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 125000002642 gamma-glutamyl group Chemical group 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- KSDAHRVZCLPQRO-YFKPBYRVSA-N (2r)-2-(prop-1-enylamino)-3-sulfanylpropanoic acid Chemical compound CC=CN[C@@H](CS)C(O)=O KSDAHRVZCLPQRO-YFKPBYRVSA-N 0.000 description 2
- 108010092760 Alliin lyase Proteins 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000007836 KH2PO4 Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IXELFRRANAOWSF-FNORWQNLSA-N (E)-Ajoene Chemical compound C=CCSS\C=C\CS(=O)CC=C IXELFRRANAOWSF-FNORWQNLSA-N 0.000 description 1
- XUHLIQGRKRUKPH-GCXOYZPQSA-N Alliin Natural products N[C@H](C[S@@](=O)CC=C)C(O)=O XUHLIQGRKRUKPH-GCXOYZPQSA-N 0.000 description 1
- WNCAVNGLACHSRZ-KAMYIIQDSA-N Allithiamine Chemical compound C=CCSSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-KAMYIIQDSA-N 0.000 description 1
- WNCAVNGLACHSRZ-UHFFFAOYSA-N Allithiamine Natural products C=CCSSC(CCO)=C(C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-UHFFFAOYSA-N 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 0 C=CCSCC(*C(CCC(C(O)=O)N)=O)C(O)=O Chemical compound C=CCSCC(*C(CCC(C(O)=O)N)=O)C(O)=O 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- XUHLIQGRKRUKPH-UHFFFAOYSA-N S-allyl-L-cysteine sulfoxide Natural products OC(=O)C(N)CS(=O)CC=C XUHLIQGRKRUKPH-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 108060008539 Transglutaminase Proteins 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- IXELFRRANAOWSF-CYBMUJFWSA-N ajoene Natural products C=CCSSC=CC[S@](=O)CC=C IXELFRRANAOWSF-CYBMUJFWSA-N 0.000 description 1
- XUHLIQGRKRUKPH-DYEAUMGKSA-N alliin Chemical compound OC(=O)[C@@H](N)C[S@@](=O)CC=C XUHLIQGRKRUKPH-DYEAUMGKSA-N 0.000 description 1
- 235000015295 alliin Nutrition 0.000 description 1
- AMPHKYRLSOPVBX-YFKPBYRVSA-N allylcysteine Chemical compound OC(=O)[C@H](CS)NCC=C AMPHKYRLSOPVBX-YFKPBYRVSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000692 cap cell Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- IXELFRRANAOWSF-UHFFFAOYSA-N cis-ajoene Natural products C=CCSSC=CCS(=O)CC=C IXELFRRANAOWSF-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000003402 intramolecular cyclocondensation reaction Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000082 organogermanium group Chemical group 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000008729 scordinin Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- -1 that is Chemical compound 0.000 description 1
- 150000008111 thiosulfinates Chemical class 0.000 description 1
- 102000003601 transglutaminase Human genes 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Fruits And Vegetables (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004381423A JP4070138B2 (ja) | 2004-03-01 | 2004-12-28 | 加工ニンニク、およびその処理方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004056880 | 2004-03-01 | ||
| JP2004381423A JP4070138B2 (ja) | 2004-03-01 | 2004-12-28 | 加工ニンニク、およびその処理方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005278635A JP2005278635A (ja) | 2005-10-13 |
| JP2005278635A5 JP2005278635A5 (enExample) | 2006-11-24 |
| JP4070138B2 true JP4070138B2 (ja) | 2008-04-02 |
Family
ID=35177685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004381423A Expired - Lifetime JP4070138B2 (ja) | 2004-03-01 | 2004-12-28 | 加工ニンニク、およびその処理方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4070138B2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999016984A1 (en) * | 1997-09-26 | 1999-04-08 | Ibiden Co., Ltd. | Composite refractory building material, method of manufacturing the same, gypsum board, and resin composition |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5834307B2 (ja) * | 2010-03-11 | 2015-12-16 | 地方独立行政法人青森県産業技術センター | アリウム属植物素材およびその製造方法 |
| JP5743444B2 (ja) * | 2010-07-08 | 2015-07-01 | 学校法人同志社 | Ｓ−アリルシステイン又はその塩を有効成分とする精子機能低下抑制剤、又は精子機能改善剤 |
| KR101352905B1 (ko) | 2012-01-18 | 2014-01-22 | 이선하 | 혈전 용해능이 강화된 흑마늘 및 그 제조방법 |
| JP5901597B2 (ja) * | 2013-09-30 | 2016-04-13 | 一丸ファルコス株式会社 | 含硫ニンニク成分を高含有する加工ニンニク抽出物及びその製造方法、これを含む医薬品、食品、飲料、化粧料 |
| JP6344924B2 (ja) * | 2014-01-30 | 2018-06-20 | 株式会社ダイセル | Ｓ−アリルシステインの製造方法 |
| JP2015144572A (ja) * | 2014-01-31 | 2015-08-13 | ユニチカ株式会社 | 加工にんにく |
| JP2015144571A (ja) * | 2014-01-31 | 2015-08-13 | ユニチカ株式会社 | Ｓ−プロペニルシステインの製造方法 |
| JP6074380B2 (ja) * | 2014-03-31 | 2017-02-01 | 株式会社ダイセル | テストステロン産生促進剤 |
| JP6697245B2 (ja) * | 2015-11-11 | 2020-05-20 | 株式会社ダイセル | 持久力向上剤 |
| JP6976515B2 (ja) * | 2017-07-21 | 2021-12-08 | 国立大学法人 筑波大学 | 睡眠改善剤 |
| JP2019037158A (ja) * | 2017-08-24 | 2019-03-14 | 日研フード株式会社 | アリウム属植物素材及び、その製造方法 |
-
2004
- 2004-12-28 JP JP2004381423A patent/JP4070138B2/ja not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999016984A1 (en) * | 1997-09-26 | 1999-04-08 | Ibiden Co., Ltd. | Composite refractory building material, method of manufacturing the same, gypsum board, and resin composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005278635A (ja) | 2005-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yisa et al. | Chemical composition of Annona senegalensis from Nupe land, Nigeria | |
| JP2005278635A (ja) | 加工ニンニク、およびその処理方法 | |
| CN102283395A (zh) | 一种羊骨素及其衍生化产品的制备方法 | |
| JP2005278635A5 (enExample) | ||
| WO2019230907A1 (ja) | 肥満抑制剤、抗認知症剤、消臭剤、抗老化剤、抗糖化剤、抗ｉ型アレルギー剤、抗高血圧剤、風味向上剤、筋肉増強剤、及び骨代謝改善剤 | |
| CN102396634A (zh) | 一种无花果果脯的加工方法 | |
| EP1786275B1 (en) | Method for enhancing the content of soybean seed gamma-aminobutyric acid | |
| DK2611454T3 (en) | Orally usable preparation, containing vegetable origin histaminase resistant to pepsin and trypsin, and process for preparation thereof | |
| JP5019645B2 (ja) | 食酢及びその製造方法 | |
| JP2018007612A (ja) | 蛋白糖化抑制機能を有する食物繊維及びその製造方法 | |
| CN109349589A (zh) | 一种用于肉制品的低盐促消化腌制料 | |
| JP5361035B2 (ja) | ラッキョウの処理方法 | |
| CN101933549A (zh) | 利用核桃叶、杜仲叶、松针制备复合茶的方法 | |
| KR20100025724A (ko) | 면역증진 조성물 및 그 제조방법 | |
| CN106860493B (zh) | 一种猕猴桃果皮提取物在制备脂肪酸合酶抑制剂中的应用 | |
| Okoroh et al. | Proximate composition, macro-mineral concentration and phytochemical screening of seeds of Citrullus lanatus | |
| Mukhtar et al. | Amino acid contents of some eggplant species grown in different region | |
| KR100620443B1 (ko) | 연옥(軟玉)이 함유된 페인트 및 그 제조방법 | |
| JP6977940B2 (ja) | ナマコサポニン含有エキス抽出および定量化方法 | |
| CN113476531A (zh) | 组合物及其在制备保护线粒体的产品中的应用 | |
| KR101286849B1 (ko) | 녹각교 농축분말의 제조방법 | |
| JP6813840B1 (ja) | ヤーコン加工品製造方法 | |
| CN103919132A (zh) | 含蚂蚁多肽、壳聚糖的蚂蚁粉的制备方法 | |
| JP2001299272A (ja) | リパーゼ阻害剤 | |
| CN113786423B (zh) | 一种金丝皇菊挥发油及其组合物在制备治疗糖脂代谢综合紊乱的产品方面的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061005 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061107 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20061107 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20061129 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061212 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070213 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070307 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070710 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070810 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20071004 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20071218 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080110 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4070138 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110125 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110125 Year of fee payment: 3 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110125 Year of fee payment: 3 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110125 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140125 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |